1833P Chemobrain: Seldom studied or reported, but apparently very common

Abstract

While studies have investigated a condition termed “chemobrain” or cancer-related cognitive impairment, the related data from the patients’ perspective remain scarce. A survey program was conducted by Kantar Health, an independent research agency, in collaboration with RoseUp, a French national cancer patient Non-Governmental Organization, to better-understand the phenomenon of chemobrain and to raise public awareness.